Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

RMD

Resmed Inc

Dec 20 • 04:00PM ET

237.27

Dollar change +5.69
Percentage change 2.46	%

Healthcare • Medical Instruments & Supplies • USA • NYSE

Peers: EW BAX BDX ZBH VNT IART TFX COO HSIC XRAY

| Held by: VTI VOO VO SPY IVV VUG VOT XLV VIG IHI

Scroll to Statements

Index	S&P 500	P/E	31.45	EPS (ttm)	7.54	Insider Own	0.79%	Shs Outstand	146.78M	Perf Week	-0.52%
Market Cap	35.69B	Forward P/E	22.89	EPS next Y	10.36	Insider Trans	-12.17%	Shs Float	145.64M	Perf Month	-1.77%
Income	1.11B	PEG	1.85	EPS next Q	2.32	Inst Own	61.44%	Short Float	5.18%	Perf Quarter	-3.62%
Sales	4.81B	P/S	7.42	EPS this Y	21.80%	Inst Trans	0.46%	Short Ratio	7.94	Perf Half Y	30.23%
Book/sh	35.39	P/B	6.70	EPS next Y	10.22%	ROA	15.94%	Short Interest	7.54M	Perf Year	36.39%
Cash/sh	2.83	P/C	83.70	EPS next 5Y	17.00%	ROE	23.56%	52W Range	164.12 - 260.49	Perf YTD	37.93%
Dividend Est.	2.20 (0.93%)	P/FCF	26.37	EPS past 5Y	19.83%	ROI	18.53%	52W High	-8.91%	Beta	0.69
Dividend TTM	2.02 (0.85%)	Quick Ratio	1.91	Sales past 5Y	12.49%	Gross Margin	56.72%	52W Low	44.57%	ATR (14)	6.19
Dividend Ex-Date	Nov 07, 2024	Current Ratio	2.92	EPS Y/Y TTM	22.74%	Oper. Margin	30.84%	RSI (14)	45.38	Volatility	3.28% 2.25%
Employees	9980	Debt/Eq	0.16	Sales Y/Y TTM	9.88%	Profit Margin	23.15%	Recom	2.12	Target Price	259.28
Option/Short	Yes / Yes	LT Debt/Eq	0.16	EPS Q/Q	41.80%	Payout	27.75%	Rel Volume	3.30	Prev Close	231.58
Sales Surprise	3.32%	EPS Surprise	7.10%	Sales Q/Q	11.08%	Earnings	Oct 24 AMC	Avg Volume	948.67K	Price	237.27
SMA20	-2.35%	SMA50	-2.18%	SMA200	7.86%	Trades		Volume	3,057,163	Change	2.46%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-13-24	Initiated	Stifel	Hold	$250
Sep-24-24	Initiated	Robert W. Baird	Outperform	$280
Sep-18-24	Downgrade	Wolfe Research	Peer Perform → Underperform	$180
Sep-04-24	Downgrade	Needham	Buy → Hold
Jun-25-24	Downgrade	Oppenheimer	Outperform → Perform
Jun-24-24	Downgrade	Citigroup	Buy → Neutral
Feb-06-24	Resumed	KeyBanc Capital Markets	Overweight	$227
Oct-27-23	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$180 → $169
Oct-12-23	Downgrade	RBC Capital Mkts	Outperform → Sector Perform	$273 → $202
Oct-09-23	Upgrade	JP Morgan	Neutral → Overweight	$210 → $170
Sep-29-23	Downgrade	Wolfe Research	Outperform → Peer Perform
Sep-06-23	Upgrade	Needham	Hold → Buy	$180
Sep-05-23	Downgrade	UBS	Buy → Neutral	$265 → $170
Aug-01-23	Upgrade	RBC Capital Mkts	Sector Perform → Outperform	$262 → $284
May-23-23	Initiated	UBS	Buy	$290
Apr-14-23	Initiated	Mizuho	Buy	$255
Jan-17-23	Upgrade	JP Morgan	Neutral → Overweight	$245
Oct-28-22	Downgrade	Citigroup	Buy → Neutral
Oct-20-22	Upgrade	BofA Securities	Neutral → Buy	$245 → $260
Oct-12-22	Initiated	Jefferies	Hold

Show Previous Ratings

Dec-20-24 05:58PM	Eli Lilly's Obesity Drug Wins Approval In Sleep Apnea; Will ResMed Dive? (Investor's Business Daily)
Dec-13-24 09:40AM	Why ResMed (RMD) is a Top Value Stock for the Long-Term (Zacks)
Dec-06-24 12:45PM	Here is Why Growth Investors Should Buy ResMed (RMD) Now (Zacks)
07:54AM	ResMed (RMD) Rose 15% in Q3 (Insider Monkey)
Dec-03-24 09:50AM	Here's Why ResMed (RMD) is a Strong Momentum Stock (Zacks)
12:45PM	Loading…
Nov-20-24 12:45PM	3 Reasons Why Growth Investors Shouldn't Overlook ResMed (RMD) (Zacks)
Nov-18-24 01:18PM	ResMed Is 80 And 80: Hits 80-Plus Relative Strength Rating After Rising 80% In A Year (Investor's Business Daily)
03:00AM	ResMed Passes Milestone, Hits 80-Plus Relative Strength Rating Benchmark After Rising 80% This Past Year (Investor's Business Daily)
Nov-14-24 07:48PM	Analyst Report: ResMed Inc. (Morningstar Research)
Nov-13-24 05:02PM	S&P 500 Gains and Losses Today: Monolithic Power Stock Drops on Risks to Nvidia Allocation (Investopedia)
Nov-12-24 09:00AM	Exploring the $188 Billion Opportunity: Why AI is Set to Transform Global Healthcare by 2030 (PR Newswire)
Nov-05-24 04:05PM	ResMed Announces Participation in the UBS Global Healthcare Conference (GlobeNewswire)
Nov-04-24 12:45PM	Is ResMed (RMD) a Solid Growth Stock? 3 Reasons to Think "Yes" (Zacks)
09:45AM	Here's Why ResMed (RMD) is a Strong Growth Stock (Zacks)
Oct-28-24 05:07PM	S&P 500 Gains and Losses Today: Oil Stocks Lose Ground as Crude Prices Fall (Investopedia)
09:50AM	Loading…
09:50AM	Why ResMed (RMD) is a Top Momentum Stock for the Long-Term (Zacks)
09:15AM	ResMed Inc. (RMD) Hits Fresh High: Is There Still Room to Run? (Zacks)
Oct-26-24 08:24AM	S&P 500 Giant Leads 5 Stocks Near Buy Points (Investor's Business Daily)
01:04AM	Decoding ResMed Inc (RMD): A Strategic SWOT Insight (GuruFocus.com)
Oct-25-24 07:34PM	Analyst Report: ResMed Inc. (Morningstar Research) +7.12%
04:27PM	ResMed Breaks Out As GLP-1 Drugs And Big Tech Help Drive A Quarterly Beat (Investor's Business Daily)
11:15AM	Sleep Apnea Device Maker ResMed Is A Durable MedTech, With Positive Fundamentals, Says Analyst (Benzinga)
10:30AM	ResMed Adds To Its Recent Sprint, Shrugging Off Worries Tied To Obesity Drugs (Investor's Business Daily)
09:15AM	My 3 Favorite Stocks to Buy Right Now (Motley Fool)
07:08AM	Q1 2025 ResMed Inc Earnings Call (Thomson Reuters StreetEvents)
03:19AM	ResMed Inc (RMD) Q1 2025 Earnings Call Highlights: Strong Financial Performance Amid Global ... (GuruFocus.com)
Oct-24-24 10:07PM	Analyst Report: ResMed Inc. (Morningstar Research)
06:00PM	ResMed (RMD) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
05:15PM	ResMed (RMD) Surpasses Q1 Earnings and Revenue Estimates (Zacks)
04:15PM	Obesity Drugs-Tied ResMed Edges Higher On Quarterly Beat (Investor's Business Daily)
04:13PM	Loading…
04:13PM	ResMed: Fiscal Q1 Earnings Snapshot (Associated Press Finance)
04:05PM	ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2025 (GlobeNewswire)
Oct-21-24 09:16AM	Unveiling ResMed (RMD) Q1 Outlook: Wall Street Estimates for Key Metrics (Zacks)
Oct-18-24 09:45AM	Why ResMed (RMD) is a Top Growth Stock for the Long-Term (Zacks)
Oct-17-24 12:45PM	ResMed (RMD) is an Incredible Growth Stock: 3 Reasons Why (Zacks)
10:01AM	ResMed (RMD) Earnings Expected to Grow: Should You Buy? (Zacks)
Oct-03-24 04:05PM	ResMed to Report First Quarter Fiscal 2025 Earnings on October 24, 2024 (GlobeNewswire)
02:00AM	ResMed Stock Is Surging. Expect More Gains for the Medical Equipment Maker. (Barrons.com)
Oct-02-24 12:00PM	ResMed (RMD) Upgraded to Buy: What Does It Mean for the Stock? (Zacks)
Sep-30-24 04:05PM	ResMed Unveils 2030 Strategy to Drive Growth, Profitability, and Shareholder Returns (GlobeNewswire)
09:48AM	UPDATE -- ResMed Unveils New Collection of Digital and Personalized Solutions designed to Improve Sleep Health (GlobeNewswire)
09:23AM	UPDATE -- ResMed Enhances CPAP Therapy with its First Fabric Mask, Designed to Make it Easier for People to Embrace Their Treatment and Improve Overall Sleep Health (GlobeNewswire)
08:10AM	ResMed Enhances CPAP Therapy with its First Fabric Mask, Designed to Make it Easier for People to Embrace Their Treatment and Improve Overall Sleep Health (GlobeNewswire)
08:01AM	ResMed Unveils New Collection of Digital and Personalized Solutions designed to Improve Sleep Health (GlobeNewswire)
Sep-18-24 05:49PM	Why ResMed Stock Tumbled by 5% Today (Motley Fool) -5.12%
05:15PM	S&P 500 Gains and Losses Today: ResMed Drops as Weight-Loss Drugs Threaten Demand (Investopedia)
01:30PM	Three stocks to note before the Fed rate cut decision (TheStreet)
12:37PM	Top Stock Movers Now: US Steel, VF Corp., ResMed, and More (Investopedia)
11:24AM	ResMed Stock Is S&P 500s Worst Performer. GLP-1 Drugs Are a Risk. (Barrons.com)
Sep-11-24 01:24AM	Insider Sale: CFO Brett Sandercock Sells 1,000 Shares of ResMed Inc (RMD) (GuruFocus.com)
Sep-10-24 04:05PM	ResMed to Host Its 2024 Investor Day on September 30, 2024, at the New York Stock Exchange (GlobeNewswire)
08:00AM	Vaping Expected to Increase COPD Health and Economic Burden by 2050 (GlobeNewswire)
Sep-09-24 07:31PM	Analyst Report: ResMed Inc. (Morningstar Research)
Sep-06-24 05:00PM	Insider Sale: Director Peter Farrell Sells 2,000 Shares of ResMed Inc (RMD) (GuruFocus.com)
Aug-30-24 09:45AM	Here's Why ResMed (RMD) is a Strong Growth Stock (Zacks)
Aug-28-24 04:05PM	ResMed Announces Participation in the Morgan Stanley 22nd Annual Global Healthcare Conference (GlobeNewswire)
Aug-27-24 05:36PM	S&P 500 Gains and Losses Today: Medical Device Makers ResMed, Insulet Lead Index (Investopedia) +7.26%
Aug-15-24 04:05PM	ResMed Expands its Board of Directors and Appoints Healthcare Executive and Seasoned Finance Leader Christopher DelOrefice to its Board (GlobeNewswire)
Aug-14-24 09:45AM	Why ResMed (RMD) is a Top Growth Stock for the Long-Term (Zacks)
Aug-12-24 03:00PM	Insider Sale: CFO Brett Sandercock Sells 1,000 Shares of ResMed Inc (RMD) (GuruFocus.com)
Aug-10-24 01:05AM	Decoding ResMed Inc (RMD): A Strategic SWOT Insight (GuruFocus.com)
Aug-09-24 02:07PM	ResMed Shares Breathing Life into Big Money Portfolios (FX Empire)
Aug-08-24 09:50AM	ResMed (RMD) is a Top-Ranked Momentum Stock: Should You Buy? (Zacks)
Aug-06-24 11:32PM	Insider Sale: President of Asia Latin America at ResMed Inc (RMD) Sells 48,000 Shares (GuruFocus.com)
12:35PM	Health Care Roundup: Market Talk (The Wall Street Journal)
Aug-02-24 08:11AM	ResMed's (RMD) Q4 Earnings Surpass Estimates, Margins Expand (Zacks)
08:10AM	Analyst Report: ResMed Inc. (Morningstar Research)
Aug-01-24 06:30PM	Compared to Estimates, ResMed (RMD) Q4 Earnings: A Look at Key Metrics (Zacks)
05:15PM	ResMed (RMD) Beats Q4 Earnings and Revenue Estimates (Zacks)
04:36PM	ResMed: Fiscal Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	ResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2024 (GlobeNewswire)
Jul-30-24 12:10PM	Why ResMed (RMD) is Poised to Beat Earnings Estimates Again (Zacks)
Jul-29-24 05:11PM	S&P 500 Gains and Losses Today: Onsemi Stock Jumps as Car Industry Drives Sales Beat (Investopedia) +5.84%
03:31PM	Wall Street is still jittery on GLP-1s (Yahoo Finance)
09:16AM	Seeking Clues to ResMed (RMD) Q4 Earnings? A Peek Into Wall Street Projections for Key Metrics (Zacks)
Jul-25-24 10:01AM	ResMed (RMD) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
Jul-11-24 09:45AM	Here's Why ResMed (RMD) is a Strong Growth Stock (Zacks)
01:30AM	GLP-1 Concerns Clobbered This Healthcare Stock. Its Time to Buy. (Barrons.com)
Jul-10-24 01:29AM	Insider Sale: CFO Brett Sandercock Sells Shares of ResMed Inc (RMD) (GuruFocus.com)
Jul-05-24 09:00AM	Falling Knives: 3 Stocks Getting the Cold Shoulder From Analysts (InvestorPlace)
Jul-03-24 04:05PM	ResMed to Report Fourth Quarter Fiscal 2024 Earnings on August 1, 2024 (GlobeNewswire)
Jul-02-24 01:47PM	How Great Is It to Have Customers That Absolutely Love You and Plan to Never Leave You? (Motley Fool)
Jul-01-24 01:38AM	Analyst Report: ResMed Inc. (Morningstar Research)
Jun-29-24 09:00AM	Sound Investments: 3 Stocks to Buy for a Good Night's Rest (InvestorPlace)
Jun-27-24 12:01PM	ResMed Stock Is Down Because of GLP-1 Concerns. It Shouldnt Be. (Barrons.com)
Jun-24-24 05:07PM	S&P 500 Gains and Losses Today: Oil Stocks Surge Amid Global Tensions, Summer Demand (Investopedia) -11.48%
04:10PM	Eli Lilly's Weight-Loss Drug Takes Down ResMed, Inspire Medical Again (Investor's Business Daily)
04:08PM	Lilly Weight-Loss Drug Data Spurs Selloff in Sleep Apnea Stocks (Bloomberg)
02:10PM	It's Not Just a Bad Day for Chip Stocks. ResMed Is the S&P 500s Top Decliner. (Barrons.com)
02:01PM	How Lilly is joining Novo in the crusade to circumvent Medicare's block on weight loss drugs (Yahoo Finance)
01:26PM	ResMed Stock Dives. Blame Eli Lillys Zepbound Trials for Sleep Apnea. (Barrons.com)
12:52PM	RXO, Alnylam Pharmaceuticals rise; ResMed, Sonoco Products fall, Monday, 6/24/2024 (Associated Press Finance)
12:29PM	Top Stock Movers Now: Affirm, Nvidia, ResMed, and More (Investopedia)
10:38AM	Why a Pair of Eli Lilly Clinical Trials Sent ResMed Stock Tumbling (Investopedia)
10:36AM	Eli Lilly seeks to expand Zepbound use to treat sleep apnea (Yahoo Finance Video)
08:40AM	Stocks to Watch Monday: Target, Meta, Coinbase, Nvidia, Apple (The Wall Street Journal)
07:52AM	ResMed Stock Is Sinking. Blame Eli Lillys Zepbound Trials for Sleep Apnea. (Barrons.com)
07:49AM	ResMed Stock Is Sinking. Blame Lillys Zepbound Trials for Sleep Apnea. (Barrons.com)
Jun-21-24 05:05PM	S&P 500 Gains and Losses Today: Index Edges Lower as AI-Fueled Rally Loses Steam (Investopedia)
Jun-19-24 09:45AM	Why ResMed (RMD) is a Top Growth Stock for the Long-Term (Zacks)

ResMed, Inc. engages in providing digital health and cloud-connected medical devices. Its digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, chronic obstructive pulmonary disease, or COPD, and other chronic diseases. The firm operates through the Sleep and Respiratory Care and Software as a Service segments. The Sleep and Respiratory Care segment engages in the sleep and respiratory disorders sector of the medical device industry. The Software as a Service segment provides business management software as a service to out-of-hospital health providers. The company was founded by Peter C. Farrell in June 1989 and is headquartered in San Diego, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Sandercock Brett	Chief Financial Officer	Dec 09 '24	Sale	244.23	1,000	244,230	93,864	Dec 11 01:17 PM
Sandercock Brett	Officer	Dec 09 '24	Proposed Sale	244.23	1,000	244,230		Dec 09 11:12 AM
FARRELL PETER C	Director	Dec 04 '24	Sale	245.65	2,000	491,300	81,218	Dec 05 06:44 PM
FARRELL PETER C	Director	Dec 04 '24	Proposed Sale	250.00	2,000	500,000		Dec 04 07:57 PM
Rider Michael J	Global General Counsel	Dec 02 '24	Sale	248.91	74	18,419	9,113	Dec 02 06:02 PM
Rider Michael J	Officer	Dec 02 '24	Proposed Sale	248.91	74	18,419		Dec 02 11:11 AM
Farrell Michael J.	Director	Nov 27 '24	Proposed Sale	250.00	2,000	500,000		Nov 27 06:17 PM
Farrell Michael J.	Chief Executive Officer	Nov 27 '24	Sale	249.66	2,000	499,330	0	Nov 27 03:19 PM
Leong Justin	Chief Product Officer	Nov 22 '24	Sale	243.09	6,160	1,497,416	21,718	Nov 25 11:14 AM
Leong Justin	Officer	Nov 22 '24	Proposed Sale	243.09	6,160	1,497,418		Nov 22 04:37 PM
De Witte Jan	Director	Nov 12 '24	Sale	248.81	796	198,053	6,723	Nov 14 11:49 AM
Farrell Michael J.	Chief Executive Officer	Nov 07 '24	Option Exercise	84.98	14,683	1,247,761	478,937	Nov 12 05:37 PM
Farrell Michael J.	Chief Executive Officer	Nov 07 '24	Sale	246.26	14,683	3,615,821	464,254	Nov 12 05:37 PM
Sandercock Brett	Chief Financial Officer	Nov 08 '24	Sale	249.00	1,000	249,000	94,864	Nov 12 04:33 PM
De Witte Jan	Director	Nov 12 '24	Proposed Sale	248.81	796	198,053		Nov 12 11:54 AM
FARRELL PETER C	Director	Nov 06 '24	Sale	248.74	2,000	497,480	83,204	Nov 08 01:15 PM
Sandercock Brett	Officer	Nov 08 '24	Proposed Sale	249.00	1,000	249,000		Nov 08 10:51 AM
Farrell Michael J.	Officer	Nov 07 '24	Proposed Sale	246.26	14,683	3,615,821		Nov 07 04:30 PM
FARRELL PETER C	Director	Nov 06 '24	Proposed Sale	248.74	2,000	497,480		Nov 06 06:22 PM
Rider Michael J	Global General Counsel	Nov 01 '24	Sale	242.00	69	16,698	10,443	Nov 05 12:20 PM
Rider Michael J	Officer	Nov 01 '24	Proposed Sale	242.00	69	16,698		Nov 01 10:27 AM
Ghoshal Kaushik	Chief Commercial Officer, SaaS	Oct 11 '24	Option Exercise	101.64	4,260	432,986	26,048	Oct 15 10:06 AM
Ghoshal Kaushik	Chief Commercial Officer, SaaS	Oct 11 '24	Sale	238.48	4,260	1,015,925	21,788	Oct 15 10:06 AM
Ghoshal Kaushik	Officer	Oct 11 '24	Proposed Sale	238.48	4,260	1,015,925		Oct 11 09:51 AM
Sandercock Brett	Chief Financial Officer	Oct 08 '24	Sale	233.47	1,000	233,470	95,812	Oct 09 04:38 PM
Farrell Michael J.	Chief Executive Officer	Oct 07 '24	Option Exercise	84.98	14,683	1,247,761	478,852	Oct 09 01:44 PM
Farrell Michael J.	Chief Executive Officer	Oct 07 '24	Sale	231.91	14,683	3,405,206	464,169	Oct 09 01:44 PM
Sandercock Brett	Officer	Oct 08 '24	Proposed Sale	233.47	1,000	233,470		Oct 08 11:08 AM
Farrell Michael J.	Officer	Oct 07 '24	Proposed Sale	231.91	14,683	3,405,206		Oct 07 04:40 PM
FARRELL PETER C	Director	Oct 02 '24	Sale	237.20	2,000	474,400	85,204	Oct 02 04:20 PM
FARRELL PETER C	Director	Oct 02 '24	Proposed Sale	238.75	2,000	477,500		Oct 02 02:46 PM
Ghoshal Kaushik	Chief Commercial Officer, SaaS	Sep 12 '24	Option Exercise	101.64	5,000	508,200	26,788	Sep 13 02:54 PM
Ghoshal Kaushik	Chief Commercial Officer, SaaS	Sep 12 '24	Sale	252.56	5,000	1,262,800	21,788	Sep 13 02:54 PM
Ghoshal Kaushik	Officer	Sep 12 '24	Proposed Sale	252.56	5,000	1,262,800		Sep 12 09:55 AM
Sandercock Brett	Chief Financial Officer	Sep 09 '24	Sale	246.42	1,000	246,420	96,812	Sep 10 09:18 PM
Farrell Michael J.	Chief Executive Officer	Sep 09 '24	Option Exercise	84.98	14,683	1,247,761	478,852	Sep 10 09:11 PM
Farrell Michael J.	Chief Executive Officer	Sep 09 '24	Sale	248.38	14,683	3,646,950	464,169	Sep 10 09:11 PM
Farrell Michael J.	Officer	Sep 09 '24	Proposed Sale	248.38	14,683	3,646,950		Sep 09 04:37 PM
Sandercock Brett	Officer	Sep 09 '24	Proposed Sale	246.42	1,000	246,420		Sep 09 11:08 AM
FARRELL PETER C	Director	Sep 04 '24	Sale	239.90	2,000	479,800	87,204	Sep 06 03:01 PM
FARRELL PETER C	Director	Sep 04 '24	Proposed Sale	244.90	2,000	489,800		Sep 04 10:58 AM
Rider Michael J	Global General Counsel	Aug 20 '24	Sale	231.00	882	203,742	10,512	Aug 21 02:29 PM
Rider Michael J	Officer	Aug 20 '24	Proposed Sale	230.74	883	203,742		Aug 20 11:14 AM
Ghoshal Kaushik	President, SaaS Business	Aug 12 '24	Option Exercise	96.41	10,000	964,056	23,032	Aug 13 03:51 PM
Ghoshal Kaushik	President, SaaS Business	Aug 12 '24	Sale	216.60	10,000	2,166,000	13,032	Aug 13 03:51 PM
Sandercock Brett	Chief Financial Officer	Aug 08 '24	Sale	212.16	1,000	212,160	89,056	Aug 12 11:57 AM
Ghoshal Kaushik	Officer	Aug 12 '24	Proposed Sale	216.60	10,000	2,166,000		Aug 12 11:25 AM
Farrell Michael J.	Chief Executive Officer	Aug 07 '24	Option Exercise	84.98	14,683	1,247,761	455,482	Aug 09 11:53 AM
Farrell Michael J.	Chief Executive Officer	Aug 07 '24	Sale	214.25	14,683	3,145,905	440,799	Aug 09 11:53 AM
Sandercock Brett	Officer	Aug 08 '24	Proposed Sale	212.16	1,000	212,160		Aug 08 12:33 PM
Farrell Michael J.	Officer	Aug 07 '24	Proposed Sale	214.25	14,683	3,145,904		Aug 07 04:47 PM
Leong Justin	President, Asia Latin America	Aug 05 '24	Sale	217.07	48,000	10,419,552	18,741	Aug 06 05:51 PM
Leong Justin	Officer	Aug 05 '24	Proposed Sale	217.07	48,000	10,419,550		Aug 05 12:52 PM
Farrell Michael J.	Chief Executive Officer	Jul 08 '24	Option Exercise	84.98	14,683	1,247,761	455,482	Jul 10 12:04 PM
Farrell Michael J.	Chief Executive Officer	Jul 08 '24	Sale	192.97	14,683	2,833,330	440,799	Jul 10 12:04 PM
Sandercock Brett	Chief Financial Officer	Jul 08 '24	Sale	194.35	1,000	194,350	90,056	Jul 09 05:27 PM
Sandercock Brett	Chief Financial Officer	Jun 10 '24	Sale	209.81	1,000	209,810	91,056	Jun 11 05:05 PM
Farrell Michael J.	Chief Executive Officer	Jun 07 '24	Option Exercise	84.98	14,683	1,247,761	455,482	Jun 10 09:58 PM
Farrell Michael J.	Chief Executive Officer	Jun 07 '24	Sale	211.66	14,683	3,107,739	440,799	Jun 10 09:58 PM
De Witte Jan	Director	May 15 '24	Sale	218.29	360	78,584	7,519	May 17 11:27 AM
Sandercock Brett	Chief Financial Officer	May 08 '24	Option Exercise	101.64	12,000	1,219,680	105,056	May 10 03:21 PM
Sandercock Brett	Chief Financial Officer	May 08 '24	Sale	211.37	13,000	2,747,810	92,056	May 10 03:21 PM
Farrell Michael J.	Chief Executive Officer	May 07 '24	Option Exercise	84.98	14,683	1,247,761	455,435	May 09 11:58 AM
Farrell Michael J.	Chief Executive Officer	May 07 '24	Sale	216.50	14,683	3,178,815	440,752	May 09 11:58 AM
Drexler Karen	Director	Apr 29 '24	Sale	214.92	425	91,341	8,446	Apr 30 02:17 PM
Rider Michael J	Global General Counsel	Mar 04 '24	Sale	180.00	81	14,580	6,607	Mar 06 08:46 PM
Rider Michael J	Global General Counsel	Mar 01 '24	Sale	173.25	200	34,650	6,688	Mar 04 07:11 PM
FARRELL PETER C	Director	Feb 22 '24	Sale	182.66	10,935	1,997,434	157,404	Feb 23 06:40 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

RMD

Resmed Inc

Upgrade your FINVIZ experience